Literature DB >> 20176790

Histophilus somni IbpA DR2/Fic in virulence and immunoprotection at the natural host alveolar epithelial barrier.

Bereket Zekarias1, Seema Mattoo, Carolyn Worby, Jason Lehmann, Ricardo F Rosenbusch, Lynette B Corbeil.   

Abstract

Newly recognized Fic family virulence proteins may be important in many bacterial pathogens. To relate cellular mechanisms to pathogenesis and immune protection, we studied the cytotoxicity of the Histophilus somni immunoglobulin-binding protein A (IbpA) direct repeat 2 Fic domain (DR2/Fic) for natural host target cells. Live virulent IbpA-producing H. somni strain 2336, a cell-free culture supernatant (CCS) of this strain, or recombinant DR2/Fic (rDR2/Fic) caused dramatic retraction and rounding of bovine alveolar type 2 (BAT2) epithelial cells. IbpA-deficient H. somni strain 129Pt and a Fic motif His(298)Ala mutant rDR2/Fic protein were not cytotoxic. The cellular mechanism of DR2/Fic cytotoxicity was demonstrated by incubation of BAT2 cell lysates with strain 2336 CCS or rDR2/Fic in the presence of [alpha-(32)P]ATP, which resulted in adenylylation of Rho GTPases and cytoskeletal disruption. Since IbpA is not secreted by type III or type IV secretion systems, we determined whether DR2/Fic entered the host cytoplasm to access its Rho GTPase targets. Although H. somni did not invade BAT2 cells, DR2/Fic was internalized by cells treated with H. somni, CCS, or the rDR2/Fic protein, as shown by confocal immunomicroscopy. Transwell bacterial migration assays showed that large numbers of strain 2336 bacteria migrated between retracted BAT2 cells, but IbpA-deficient strain 129Pt did not cross a monolayer unless the monolayer was pretreated with strain 2336 CCS or rDR2/Fic protein. Antibody to rDR2/Fic or passively protective convalescent-phase serum blocked IbpA-mediated cytotoxicity and inhibited H. somni transmigration across BAT2 monolayers, confirming the role of DR2/Fic in pathogenesis and corresponding to the results for in vivo protection in previous animal studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176790      PMCID: PMC2863524          DOI: 10.1128/IAI.01277-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Two-partner secretion in Gram-negative bacteria: a thrifty, specific pathway for large virulence proteins.

Authors:  F Jacob-Dubuisson; C Locht; R Antoine
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

2.  Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors.

Authors:  Xiaoxiao Pan; Anja Lührmann; Ayano Satoh; Michelle A Laskowski-Arce; Craig R Roy
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

3.  Genetic and functional analysis of Haemophilus somnus high molecular weight-immunoglobulin binding proteins.

Authors:  Yuichi Tagawa; Jerry D Sanders; Ikuo Uchida; Felix D Bastida-Corcuera; Kenji Kawashima; Lynette B Corbeil
Journal:  Microb Pathog       Date:  2005-09-19       Impact factor: 3.738

4.  Viable "Haemophilus somnus" induces myosin light-chain kinase-dependent decrease in brain endothelial cell monolayer resistance.

Authors:  E Behling-Kelly; David McClenahan; K S Kim; C J Czuprynski
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

5.  Diagnostic exercise: Myocarditis due to Histophilus somni in feedlot and backgrounded cattle.

Authors:  D O'Toole; T Allen; R Hunter; L B Corbeil
Journal:  Vet Pathol       Date:  2009-05-09       Impact factor: 2.221

6.  AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling.

Authors:  Melanie L Yarbrough; Yan Li; Lisa N Kinch; Nick V Grishin; Haydn L Ball; Kim Orth
Journal:  Science       Date:  2008-11-27       Impact factor: 47.728

7.  Two linked genes for outer membrane proteins are absent in four non-disease strains of Haemophilus somnus.

Authors:  S P Cole; D G Guiney; L B Corbeil
Journal:  Mol Microbiol       Date:  1992-07       Impact factor: 3.501

8.  Antibody response to Haemophilus somnus Fc receptor.

Authors:  M Yarnall; L B Corbeil
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

9.  Proposal of Histophilus somni gen. nov., sp. nov. for the three species incertae sedis 'Haemophilus somnus', 'Haemophilus agni' and 'Histophilus ovis'.

Authors:  Øystein Angen; Peter Ahrens; Peter Kuhnert; Henrik Christensen; Reinier Mutters
Journal:  Int J Syst Evol Microbiol       Date:  2003-09       Impact factor: 2.747

10.  Protective ability and specificity of convalescent serum from calves with Haemophilus somnus pneumonia.

Authors:  R P Gogolewski; S A Kania; T J Inzana; P R Widders; H D Liggitt; L B Corbeil
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

View more
  29 in total

1.  CryoAPEX - an electron tomography tool for subcellular localization of membrane proteins.

Authors:  Ranjan Sengupta; Michael J Poderycki; Seema Mattoo
Journal:  J Cell Sci       Date:  2019-03-18       Impact factor: 5.285

Review 2.  Structure and function of Fic proteins.

Authors:  Craig R Roy; Jacqueline Cherfils
Journal:  Nat Rev Microbiol       Date:  2015-08-24       Impact factor: 60.633

Review 3.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

Review 4.  Enzymes Involved in AMPylation and deAMPylation.

Authors:  Amanda K Casey; Kim Orth
Journal:  Chem Rev       Date:  2017-08-18       Impact factor: 60.622

5.  Alpha-Synuclein Is a Target of Fic-Mediated Adenylylation/AMPylation: Possible Implications for Parkinson's Disease.

Authors:  Anwesha Sanyal; Sayan Dutta; Ali Camara; Aswathy Chandran; Antonius Koller; Ben G Watson; Ranjan Sengupta; Daniel Ysselstein; Paola Montenegro; Jason Cannon; Jean-Christophe Rochet; Seema Mattoo
Journal:  J Mol Biol       Date:  2019-04-27       Impact factor: 5.469

6.  Two outer membrane lipoproteins from Histophilus somni are immunogenic in rabbits and sheep and induce protection against bacterial challenge in mice.

Authors:  Carolina Guzmán-Brambila; Argelia E Rojas-Mayorquín; Beatriz Flores-Samaniego; Daniel Ortuño-Sahagún
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

7.  YopT domain of the PfhB2 toxin from Pasteurella multocida: protein expression, characterization, crystallization and crystallographic analysis.

Authors:  Sanjeev Kumar; Victoria Hedrick; Seema Mattoo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-02-26       Impact factor: 1.056

8.  Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.

Authors:  Robert Jordan; Matt Shao; Richard L Mackman; Michel Perron; Tomas Cihlar; Sandy A Lewis; Eugene J Eisenberg; Anne Carey; Robert G Strickley; Jason W Chien; Mark L Anderson; Heather A McEligot; Nicole E Behrens; Laurel J Gershwin
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

9.  Structural basis of Fic-mediated adenylylation.

Authors:  Junyu Xiao; Carolyn A Worby; Seema Mattoo; Banumathi Sankaran; Jack E Dixon
Journal:  Nat Struct Mol Biol       Date:  2010-07-11       Impact factor: 15.369

Review 10.  How Bacteria Subvert Animal Cell Structure and Function.

Authors:  Alyssa Jimenez; Didi Chen; Neal M Alto
Journal:  Annu Rev Cell Dev Biol       Date:  2016-05-04       Impact factor: 13.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.